Hovsep hols a PhD in medical sciences with an engineering background in biotechnology and business development experience. His professional goal revolves around improving human health, communicating evidence-based medicine and developing ventures. In 2014, Hovsep obtained his PhD within Cardio-Metabolic diseases at Karolinska Institutet. After two postdoctoral research years, one within CVD and stroke and the second within colorectal cancer, Hovsep transitioned into an industry role evolving around next-generation therapy at Miltenyi Biotec as regional account manager. Since January 2017, Hovsep works as Scientific Advisor (MSL) at Bayer within Cardiovascular diseases. He stays affiliated to KI for basic research within Cardiovascular and cancer genomics.